Antiproliferative Activity of Vitamin D Compounds in Combination with Cytostatics
Calcitriol is a potent antiproliferative agent against various tumour cells in vitro. Here, the results of a study on vitamin D compounds (calcitriol's analogues PRI-1906 and PRI-2191) as potential agents in combined antitumour therapy in vitro are presented. Applying antiproliferative SRB and...
Saved in:
Published in | Anticancer research Vol. 26; no. 4A; pp. 2701 - 2705 |
---|---|
Main Authors | , , , , , |
Format | Journal Article Conference Proceeding |
Language | English |
Published |
Attiki
International Institute of Anticancer Research
01.07.2006
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Calcitriol is a potent antiproliferative agent against various tumour cells in vitro. Here, the results of a study on vitamin
D compounds (calcitriol's analogues PRI-1906 and PRI-2191) as potential agents in combined antitumour therapy in vitro are
presented. Applying antiproliferative SRB and MTT assays, the growth inhibitory effects of the vitamin D compounds, applied
alone or in combination with either cisplatin or doxorubicin, were measured. The following cancer cell lines were employed:
A549 (human non-small cell lung carcinoma), B16 (murine melanoma), CCRF, HL-60 (human leukaemia), SW707 (human colon cancer),
MCF-7, T47D (human breast cancer), WEHI-3 (mouse leukaemia) and normal cells: BALB 3T3 (normal murine fibroblast cell line).
It was shown that the treatment of tumour cells, which are sensitive to vitamin D compounds, with the combination of vitamin
D compounds and cytostatics decreased the inhibitory concentration 50% (IC 50 ) values compared with the effects of the cytostatics applied alone. |
---|---|
AbstractList | Calcitriol is a potent antiproliferative agent against various tumour cells in vitro. Here, the results of a study on vitamin D compounds (calcitriol's analogues PRI-1906 and PRI-2191) as potential agents in combined antitumour therapy in vitro are presented. Applying antiproliferative SRB and MTT assays, the growth inhibitory effects of the vitamin D compounds, applied alone or in combination with either cisplatin or doxorubicin, were measured. The following cancer cell lines were employed: A549 (human non-small cell lung carcinoma), B16 (murine melanoma), CCRF, HL-60 (human leukaemia), SW707 (human colon cancer), MCF-7, T47D (human breast cancer), WEHI-3 (mouse leukaemia) and normal cells: BALB 3T3 (normal murine fibroblast cell line). It was shown that the treatment of tumour cells, which are sensitive to vitamin D compounds, with the combination of vitamin D compounds and cytostatics decreased the inhibitory concentration 50% (IC50) values compared with the effects of the cytostatics applied alone. Calcitriol is a potent antiproliferative agent against various tumour cells in vitro. Here, the results of a study on vitamin D compounds (calcitriol's analogues PRI-1906 and PRI-2191) as potential agents in combined antitumour therapy in vitro are presented. Applying antiproliferative SRB and MTT assays, the growth inhibitory effects of the vitamin D compounds, applied alone or in combination with either cisplatin or doxorubicin, were measured. The following cancer cell lines were employed: A549 (human non-small cell lung carcinoma), B16 (murine melanoma), CCRF, HL-60 (human leukaemia), SW707 (human colon cancer), MCF-7, T47D (human breast cancer), WEHI-3 (mouse leukaemia) and normal cells: BALB 3T3 (normal murine fibroblast cell line). It was shown that the treatment of tumour cells, which are sensitive to vitamin D compounds, with the combination of vitamin D compounds and cytostatics decreased the inhibitory concentration 50% (IC 50 ) values compared with the effects of the cytostatics applied alone. |
Author | MARZENA PELCZYNSKA IWONA JAROSZEWICZ ADAM OPOLSKI ANDRZEJ KUTNER MAGDALENA MACIEJEWSKA MARTA SWITALSKA |
Author_xml | – sequence: 1 givenname: Marzena surname: PELCZYNSKA fullname: PELCZYNSKA, Marzena organization: Department of Experimental Oncology, Institute of Immunology and Experimental Therapy, 12 R. Weigla St, 53-114 Wroclaw, Poland – sequence: 2 givenname: Marta surname: SWITALSKA fullname: SWITALSKA, Marta organization: Department of Experimental Oncology, Institute of Immunology and Experimental Therapy, 12 R. Weigla St, 53-114 Wroclaw, Poland – sequence: 3 givenname: Magdalena surname: MACIEJEWSKA fullname: MACIEJEWSKA, Magdalena organization: Department of Experimental Oncology, Institute of Immunology and Experimental Therapy, 12 R. Weigla St, 53-114 Wroclaw, Poland – sequence: 4 givenname: Iwona surname: JAROSZEWICZ fullname: JAROSZEWICZ, Iwona organization: Department of Experimental Oncology, Institute of Immunology and Experimental Therapy, 12 R. Weigla St, 53-114 Wroclaw, Poland – sequence: 5 givenname: Andrzej surname: KUTNER fullname: KUTNER, Andrzej organization: Pharmaceutical Research Institute, 8 Rydygiera St, 01-793 Warsaw, Poland – sequence: 6 givenname: Adam surname: OPOLSKI fullname: OPOLSKI, Adam organization: Department of Experimental Oncology, Institute of Immunology and Experimental Therapy, 12 R. Weigla St, 53-114 Wroclaw, Poland |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=18043350$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/16886680$$D View this record in MEDLINE/PubMed |
BookMark | eNpFkEtLxDAUhYOMOA_9C5KN7gp5NI8uS33CgAjqNqRtaiNtMjapw_x7A47M6nAuH-fec9dg4bwzZ2CFRYEzwShagBUiDGUCIbYE6xC-EOK8kPQCLDGXknOJVuC1dNHuJj_Yzkw62h8DyyaJjQfoO_hhox6tg3ew8uPOz64NMNlkausS7h3c29jD6hB9iGnQhEtw3ukhmKujbsD7w_1b9ZRtXx6fq3Kb9USgmNU6bwU3tCUcM4IRFTo3pm5oLjniNSs6Zgre1RLnRLSGF7zVBueoZkRLKSTdgNu_3HT992xCVKMNjRkG7Yyfg-JSYMwESeD1EZzr0bRqN9lRTwf1_4QE3BwBHRo9dJN2jQ0nTqKcUoZOG3v72e_tZFQY9TCkWKr0RLjKS5W6YfoL5x51Ig |
ContentType | Journal Article Conference Proceeding |
Copyright | 2006 INIST-CNRS |
Copyright_xml | – notice: 2006 INIST-CNRS |
DBID | IQODW CGR CUY CVF ECM EIF NPM 7X8 |
DatabaseName | Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1791-7530 |
EndPage | 2705 |
ExternalDocumentID | 16886680 18043350 ar26_4A_2701 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | - 23M 53G 55 5GY 5RE 5VS ABFLS ADACO ADBBV ADBIT AENEX AFFNX ALMA_UNASSIGNED_HOLDINGS BAWUL DIK EBS EJD F5P H13 KQ8 L7B OK1 P2P RHF RHI SJN UDS VRB X7M ZGI ZXP --- .55 .GJ AAUGY BTFSW IQODW W8F AIZAD CGR CUY CVF ECM EIF NPM 7X8 |
ID | FETCH-LOGICAL-h270t-ba4d76e3d261521037a4eebc348606b59f5e96fb81427de696dae140b52a88783 |
ISSN | 0250-7005 |
IngestDate | Fri Aug 16 21:06:22 EDT 2024 Sat Sep 28 07:41:02 EDT 2024 Sun Oct 22 16:09:44 EDT 2023 Tue Nov 23 16:34:04 EST 2021 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 4A |
Keywords | Antineoplastic agent DNA topoisomerase (ATP-hydrolysing) Enzyme Cholecalciferol(1,25-dihydroxy) Cytostatic Calcitriol Enzyme inhibitor Malignant tumor Doxorubicin In vitro Biological activity Cisplatin Alkylating agent Isomerases Cancerology Vitamin D Analog Anthracyclins Combined treatment in vitro assay vitamin D analogues Platinum II Complexes Cancer |
Language | English |
License | CC BY 4.0 |
LinkModel | OpenURL |
MeetingName | Vitamin D analogs in cancer prevention and therapy |
MergedId | FETCHMERGED-LOGICAL-h270t-ba4d76e3d261521037a4eebc348606b59f5e96fb81427de696dae140b52a88783 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 16886680 |
PQID | 68711572 |
PQPubID | 23479 |
PageCount | 5 |
ParticipantIDs | proquest_miscellaneous_68711572 pubmed_primary_16886680 pascalfrancis_primary_18043350 highwire_smallpub3_ar26_4A_2701 |
PublicationCentury | 2000 |
PublicationDate | 2006-07-01 |
PublicationDateYYYYMMDD | 2006-07-01 |
PublicationDate_xml | – month: 07 year: 2006 text: 2006-07-01 day: 01 |
PublicationDecade | 2000 |
PublicationPlace | Attiki |
PublicationPlace_xml | – name: Attiki – name: Greece |
PublicationTitle | Anticancer research |
PublicationTitleAlternate | Anticancer Res |
PublicationYear | 2006 |
Publisher | International Institute of Anticancer Research |
Publisher_xml | – name: International Institute of Anticancer Research |
SSID | ssj0066983 |
Score | 2.0105052 |
Snippet | Calcitriol is a potent antiproliferative agent against various tumour cells in vitro. Here, the results of a study on vitamin
D compounds (calcitriol's... Calcitriol is a potent antiproliferative agent against various tumour cells in vitro. Here, the results of a study on vitamin D compounds (calcitriol's... |
SourceID | proquest pubmed pascalfrancis highwire |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 2701 |
SubjectTerms | Animals Antineoplastic Combined Chemotherapy Protocols - pharmacology BALB 3T3 Cells Biological and medical sciences Calcitriol - administration & dosage Calcitriol - analogs & derivatives Calcitriol - pharmacology Cell Growth Processes - drug effects Cell Line, Tumor Cisplatin - administration & dosage Dihydroxycholecalciferols - administration & dosage Dihydroxycholecalciferols - pharmacology Doxorubicin - administration & dosage Drug Screening Assays, Antitumor Humans Medical sciences Mice Tumors |
Title | Antiproliferative Activity of Vitamin D Compounds in Combination with Cytostatics |
URI | http://ar.iiarjournals.org/content/26/4A/2701.abstract https://www.ncbi.nlm.nih.gov/pubmed/16886680 https://search.proquest.com/docview/68711572 |
Volume | 26 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLaqISHeuAwojOEH3qagXG3nMWqL1u7CWDt19CWyE3tD2pKpTYfYv-Afc5yry4YQvCR1rFjROV-Pz7G_c4zQBy4V5WniWn4C4Sp4xMLilEmLJswTjgoT8JE02-KY7J_5k_PgvNf7abCW1oX4mNw9mFfyP1qFZ6BXnSX7D5ptB4UH8Bv0C1fQMFzv6_jBqSbK9Fo0KG65V5ftuTRBoLtv9Lk8StYVvnUew21Nw4A7v_6W7Q1LYrk-X6kkx0IDwuUKGBUz_UeR68Qjgxh_MjocLL4eTw-iOuHnTmatgZ_Ox7PosOsr2p6jaDAeTUbztu9C85m7NyfR6efpYjQfDxal8fqe133GugQ11yU2FzQ3mA-GaE5N0VRWD3wyi9p2tdUtK6tMQ8eCuMo2zXaVaF_D049MI0zr75BNM-hmu2aH_7dJsKUmOkyXdNOrQI9cLwy0oRyOD5rJnZCwquzafKVRV1rTavkK_lmqOhLlzzFL6bvMnqLtLqsTn7QgeoZ6MnuOHh_V5IoX6Ms9tOAGLThXuEYLHuIWLRiaBlqwRgs20LKNzj6NZoN9qz5xw7oEKRWW4H5KifRSiKvBr7M9yn0pReLpo8qICEIVyJAowRzfpakkIUm5hBBdBC6H2Yp5L9FWlmfyNcKpz0PwNqWXuMoPuOBuIogijiIpo0ni9NH7RnDx6ppfXYGAvJgvXRL7UaxV2Ee7G_KMb6r6K3GjIhiiEXAMRlHvdPFM5utVTBjVRaTcPnpVyb17lzBGCLPf_G3wt-hJh-odtFUs1_Id-J-F2C0R8QtVSo9k |
link.rule.ids | 310,311,315,786,790,795,796,23958,23959,25170 |
linkProvider | Flying Publisher |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=proceeding&rft.title=Anticancer+research&rft.atitle=Antiproliferative+activity+of+vitamin+D+compounds+in+combination+with+cytostatics&rft.au=PELCZYNSKA%2C+Marzena&rft.au=SWITALSKA%2C+Marta&rft.au=MACIEJEWSKA%2C+Magdalena&rft.au=JAROSZEWICZ%2C+Iwona&rft.date=2006-07-01&rft.pub=International+Institute+of+Anticancer+Research&rft.issn=0250-7005&rft.eissn=1791-7530&rft.volume=26&rft.issue=4A&rft.spage=2701&rft.epage=2705&rft.externalDBID=n%2Fa&rft.externalDocID=18043350 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0250-7005&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0250-7005&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0250-7005&client=summon |